Moreover, the oncogenic properties of KRas-G12D were found to rely on the KRAS-PI3Kα interaction, since oncogenesis was significantly inhibited, with tumour cells undergoing apoptosis before the formation of macroscopic tumours (Gupta et al., 2007). The gene discussed is KRAS; the disease is neoplasm.